References
- Basu I, Agarwal M, Shah V, et al. (2021). Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study. Hum Vaccin Immunother 1–10. doi:10.1080/21645515.2021.1885278.
- Berteau C, Filipe-Santos O, Wang T, et al. (2015). Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance. Med Devices 8:473–84.
- Cox D, Stone J. (2006). Managing self-injection difficulties in patients with relapsing-remitting multiple sclerosis. J Neurosci Nurs 38:167–71.
- de Menezes Martins R, Curran B, Maia Mde L, et al. (2015). Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: a randomized non-inferiority study. Contemp Clin Trials 41:1–8.
- Deacon B, Abramowitz J. (2006). Fear of needles and vasovagal reactions among phlebotomy patients. J Anxiety Disord 20:946–60.
- Devonshire V, Lapierre Y, Macdonell R, et al.; for the GAP Study Group. (2011). The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis. Eur J Neurol 18:69–77.
- FDA. 2007. Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. CBER.
- Heise T, Nosek L, Dellweg S, et al. (2014). Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial. Diabetes Obes Metab 16:971–6.
- Kojic N, Goyal P, Lou CH, Corwin MJ. (2017). An innovative needle-free injection system: comparison to 1 ml standard subcutaneous injection . AAPS PharmSciTech 18:2965–70.
- Love AS, Love RJ. (2021). Considering needle phobia among adult patients during mass COVID-19 vaccinations. J Prim Care Community Health 12:21501327211007393.
- Orenius T, LicPsych H, Saila K, et al. (2018). Fear of injections and needle phobia among children and adolescents: an overview of psychological, behavioral, and contextual factors. SAGE Open Nurs 4:2377960818759442.
- Rosenfeld RG, Bakker B. (2008). Compliance and persistence in pediatric and adult patients receiving growth hormone therapy. Endocr Pract 14:143–54.
- Schiff M, Koo J, Jin E, et al. (2016). Usability and acceptability of the abatacept pre-filled autoinjector for the subcutaneous treatment of rheumatoid arthritis. Adv Ther 33:199–213.
- Schneider A, Mueller P, Jordi C, et al. (2020). Hold the device against the skin: the impact of injection duration on user's force for handheld autoinjectors. Expert Opin Drug Deliv 17:225–36.
- Taberner A, Hogan NC, Hunter IW. (2012). Needle-free jet injection using real-time controlled linear Lorentz-force actuators. Med Eng Phys 34:1228–35.
- Taddio A, McMurtry CM, Shah V, et al. (2015). Reducing pain during vaccine injections: clinical practice guideline. CMAJ 187:975–82.
- Taddio A, Ipp M, Thivakaran S, et al. (2012). Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine 30:4807–12.
- van den Bemt BJF, Gettings L, Domańska B, et al. (2019). A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience. Drug Deliv 26:384–92.